Literature DB >> 16208399

Neonatal morbidity and growth in very low birth-weight infants after multiple courses of antenatal steroids.

Praveen Kumar1, Roopa Seshadri.   

Abstract

OBJECTIVE: To evaluate the neonatal morbidity and the growth in very low birth-weight (VLBW) infants after exposure to multiple courses of antenatal steroids. STUDY
DESIGN: A total of 319 VLBW infants were placed in one of the two groups based on exposure to antenatal steroids: Group 1: less than two complete courses; Group 2: two complete courses or more. Anthropometric measurements at birth and discharge and neonatal morbidity were recorded. Composite morbidity was defined as presence of any of the following: death, chronic lung disease, major intraventricular hemorrhage and periventricular leukomalacia.
RESULTS: The composite morbidity was not significantly different between the two groups (p=0.26). A significantly higher percentage of infants born after multiple courses of antenatal steroids had head circumference below 10th percentile at discharge (23 vs 9%, adjusted OR, 3.25, (95% CI, 1.4, 7.3); p=0.015).
CONCLUSIONS: Multiple courses of antenatal steroids may predispose VLBW infants to impairment of postnatal somatic growth without providing any additional benefit for immediate neonatal outcome. Journal of Perinatology (2005) 25, 698-702. doi:10.1038/sj.jp.7211393; published online 6 October 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208399     DOI: 10.1038/sj.jp.7211393

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  Auditory neural maturation after exposure to multiple courses of antenatal betamethasone in premature infants as evaluated by auditory brainstem response.

Authors:  Sanjiv B Amin; Ronnie Guillet
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

2.  The role of antenatal corticosteroids for improving the maturation of choroid plexus capillaries in fetal mice.

Authors:  Jing Liu; Zhi-Chun Feng; Xiao-Juan Yin; Hui Chen; Jing Lu; Xin Qiao
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.